Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation
暂无分享，去创建一个
L. Bouadma | M. Wolff | P. Nataf | L. Massias | S. Ruiz | D. da Silva | E. Papy
[1] Pascal Leprince,et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock* , 2008, Critical care medicine.
[2] Thierry Buclin,et al. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] J. Arnold,et al. Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment , 2007, Intensive Care Medicine.
[4] F. Dromer,et al. In Vitro Evaluation of Double and Triple Combinations of Antifungal Drugs against Aspergillus fumigatus and Aspergillus terreus , 2004, Antimicrobial Agents and Chemotherapy.
[5] M. Buck. Pharmacokinetic Changes During Extracorporeal Membrane Oxygenation , 2003, Clinical pharmacokinetics.